Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v8-EN
Language English English
Date Updated 2019-02-01 2018-10-11
Drug Identification Number 02230394 02230394
Brand name TEVA-OXYBUTYNIN TEVA-OXYBUTYNIN
Common or Proper name OXYBUTYNIN OXYBUTYNIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients OXYBUTYNIN CHLORIDE OXYBUTYNIN CHLORIDE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-11-01 2017-11-01
Estimated end date 2019-02-01 2019-02-01
Actual end date 2019-01-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments